Merck Announces Fourth-Quarter and Full-Year 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Merck (MRK) Tops Q4 EPS by 1c, Offers FY Guidance
February 1, 2019 6:47 AM ESTMerck (NYSE: MRK) reported Q4 EPS of $1.04, $0.01 better than the analyst estimate of $1.03. Revenue for the quarter came in at $11 billion versus the consensus estimate of $10.94 billion.
GUIDANCE:
Merck sees FY2019 EPS of $4.57-$4.72, versus the consensus of $4.69. Merck sees... More
